Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis

Brain, Behavior, and Immunity

Volumn 22, Issue 1, 2008, Pages 3-14

  Smith, Eric M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

ACTH; CRF; Endorphin; HPA axis; Leukocytes; Neuroendocrine; Neuroimmunology; NF B; Psychoneuroimmunology

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; ENDORPHIN; HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; NEUROPEPTIDE; PROOPIOMELANOCORTIN;

B LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EDITORIAL; HELPER CELL; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; NEUROIMMUNOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PSYCHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; ENDORPHINS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNE SYSTEM; INFLAMMATION; LEUKOCYTES; NEUROPEPTIDES; PITUITARY-ADRENAL SYSTEM; SIGNAL TRANSDUCTION;

EID: 36749097276     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2007.08.005     Document Type: Editorial

References (126)

1. Aird F., Clevenger C.V., Prystowsky M.B., and Redei E. Corticotropin-releasing factor mRNA in rat thymus and spleen. Proc. Natl. Acad. Sci. USA 90 (1993) 7104-7108
2. Alvarez-Mon M., Kehrl J.H., and Fauci A.S. A potential role for adrenocorticotropin in regulating human B lymphocyte functions. J. Immunol. 135 (1985) 3823-3826
3. Audhya T., Zwickler D., Hutchinson B., Brown C., and Hollander C.S. Stress-induced changes in corticotropin-releasing factor (CRF) in immune tissues and hypothalamus: studies toward defining a role for CRF in neuroimmunomodulation. Trans. Assoc. Am. Physician. 101 (1988) 62-69
4. Auphan N., DiDonato J.A., Rosette C., Helmberg A., and Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of its synthesis. Science 270 (1995) 286-290
5. Baeuerle P.A., and Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12 (1994) 141-179
6. Baigent S.M. Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 22 (2001) 809-820
7. Baigent S.M., and Lowry P.J. mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J. Mol. Endocrinol. 25 (2000) 43-52
8. Bamberger C.M., Wald M., Bamberger A.M., Ergun S., Beil F.U., and Schulte H.M. Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J. Clin. Endocrinol. Metab. 83 (1998) 708-711
9. Bayle J.D., Guellati M., Ibos F., and Roux J. Brucella abortus antigen stimulates the pituitary-adrenal axis through the extrapituitary B-lymphoid system. Progr. Neuroendocrinimmunol. 4 (1991) 99-105
10. Bellinger D., Felten D.L., Lorton D., and Brouxhon S.M. Effects of interleukin-2 on the expression of corticotropin-releasing hormone in nerves and lymphoid cells in secondary lymphoid organs from the Fischer 344 rat. J. Neuroimmunol. 119 (2001) 37-50
11. Berkenbosch F., van Oers J., del Rey A., Tilders F.X., and Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238 (1987) 524-526
12. Blalock J.E., and Smith E.M. Human leukocyte interferon: Structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc. Natl. Acad. Sci. USA 77 (1980) 5972-5974
13. Blalock J.E., and Stanton J.D. Common pathways of interferon and hormonal action. Nature 283 (1980) 406-408
14. Blalock J.E., Whitaker J.N., Benveniste E.N., and Bost K.L. Use of peptides encoded by complementary RNA for generating anti-idiotypic antibodies of predefined specificity. Methods Enzymol. 178 (1989) 63-74
15. Bost K.L., Clarke B.L., Xu J.C., Kiyono H., McGhee J.R., and Pascual D. Modulation of IgM secretion and H chain mRNA expression in CH12.LX.C4.5F5 B cells by adrenocorticotropic hormone. J. Immunol. 145 (1990) 4326-4331
16. Brooks K.S. Adrenocorticotropin (ACTH) functions as a late-acting B cell growth factor and synergizes with interleukin 5. J. Mol. Cell. Immunol. 4 (1990) 327-337
17. Buzzetti R., McLoughlin L., Lavender P.M., Clark A.J., and Rees L.H. Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J. Clin. Invest. 83 (1989) 733-737
18. Carr D.J., Rogers T.J., and Weber R.J. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis. Proc. Soc. Exp. Biol. Med. 213 (1996) 248-257
19. Clarke B.L., Gebhardt B.M., and Blalock J.E. Mitogen-stimulated lymphocytes release biologically active corticotropin. Endocrinology 132 (1993) 983-988
20. Dautzenberg F.M., and Hauger R. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23 (2002) 71-77
21. Dave J., Eiden L., and Eskay R. Corticotropin-releasing factor binding to peripheral tissue and activation of the adenylate cyclase-adenosine 3′,5′-monophosphate system. Endocrinology 116 (1985) 2152-2159
22. Davila D.R., Brief S., Simon J., Hammer R.E., Brinster R.L., and Kelley K.W. Role of growth hormone in regulating T-dependent immune events in aged, nude, and transgenic rodents. J. Neurosci. Res. 18 (1987) 108-116
23. Dunn A.J., Powell M.L., Moreshead W.V., Gaskin J.M., and Hall N.R. Effects of Newcastle disease virus administration to mice on the metabolism of cerebral biogenic amines, plasma corticosterone, and lymphocyte proliferation. Brain, Behav. Immun. 1 (1987) 216-230
24. DuPont A.G., Somers G., Van Steirteghem A.C., Warson F., and Vanhaelst L. Ectopic adrenocorticotropin production: disappearance after removal of inflammatory tissue. J. Clin. Endocrinol. Metab. 58 (1984) 654-658
25. Ekman R., Servenius B., Castro M.G., Lowry P.J., Cederlund A.S., Bergman O., and Sjogren H.O. Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes. J. Neuroimmunol. 44 (1993) 7-13
26. Fehm H.L., Holl R., Spath-Schwalbe E., Born J., and Voigt K.H. Ability of corticotropin releasing hormone to stimulate cortisol secretion independent from pituitary adrenocorticotropin. Life Sci. 42 (1988) 679-686
27. Galin F.S., LeBoeuf R.D., and Blalock J.E. A lymphocyte mRNA encodes the adrenocorticotropin/β-lipotropin region of the pro-opiomelanocortin gene. Progr. Neuroendocrinimmunol. 3 (1990) 205-208
28. Harbour-McMenamin, D., 1986. B lymphocyte enriched populations produce immunoreactive endorphin that binds to delta opiate receptors and may play a role in endotoxic shock. ICSU Short Report 4, 378-379.
29. Harbour-McMenamin D., Smith E.M., and Blalock J.E. Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins. Infect. Immun. 48 (1985) 813-817
30. Hashemi F.B., Hughes T.K., and Smith E.M. Human immunodeficiency virus induction of corticotropin in lymphoid cells. J. Clin. Endocrinol. Metab. 83 (1998) 4373-4381
31. Hassan A.H., Pzewlocki R., Herz A., and Stein C. Dynorphin, a preferential ligand for kappa-opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat. Neurosci. Lett. 140 (1992) 85-88
32. Heijnen C.J., Zijlstra J., Kavelaars A., Croiset G., and Ballieux R.E. Modulation of the immune response by POMC-derived peptides. I. Influence on proliferation of human lymphocytes. Brain Behav. Immun. 1 (1987) 284-291
33. Hughes T.K., and Chin R. Interactions of neuropeptides and lymphokines. In: Scharrer B., Smith E.M., and Stefano G.B. (Eds). Neuropeptides and Immunoregulation (1994), Springer-Verlag, Berlin 100-115
34. Hughes T.K., and Smith E.M. Corticotropin (ACTH) induction of tumor necrosis factor alpha by monocytes. J. Biol. Regul. Homeost. Agents 3 (1989) 163-166
35. Irwin M., Hauger R., and Brown M. Central corticotropin-releasing hormone activates the sympathetic nervous system and reduces immune function: increased responsivity of the aged rat. Endocrinology 131 (1992) 1047-1053
36. Irwin M., Hauger R., Brown M., and Britton K. CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am. J. Physiol.-Regul. Integr. Comp. Physiol. (1988) R744-R747
37. Irwin M., Vale W., and Britton K. Central corticotrtopin-releasing factor suppresses natural killer cytotoxicity. Brain Behav. Immun. 1 (1987) 81-87
38. Jessop D.S., Harbuz M.S., Snelson C.L., Dayan C.M., and Lightman S.L. An antisense oligodeoxynucleotide complementary to corticotropin-releasing hormone mRNA inhibits rat splenocyte proliferation in vitro. J. Neuroimmunol. 75 (1997) 135-140
39. Jessop D.S., Harbuz M.S., and Lightman S.L. CRH in chronic inflammatory stress. Peptides 22 (2001) 803-807
40. Jessop D.S., Lightman S.L., and Chowdrey H.S. Effects of a chronic inflammatory stress on levels of pro-opiomelanocortin-derived peptides in the rat spleen and thymus. J. Neuroimmunol. 49 (1994) 197-203
41. Jessop D.S., Renshaw D., Lightman S.L., and Harbuz M.S. Changes in ACTH and beta-endorphin immunoreactivity in immune tissues during a chronic inflammatory stress are not correlated with changes in corticotropin-releasing hormone and arginine vasopressin. J. Neuroimmunol. 60 (1995) 29-35
42. Johnson H.M., Smith E.M., Torres B.A., and Blalock J.E. Regulation of the in vitro antibody response by neuroendocrine hormones. Proc. Natl. Acad. Sci USA 79 (1982) 4171-4174
43. Johnson H.M., Torres B.A., Smith E.M., Dion L.D., and Blalock J.E. Regulation of lymphokine (gamma-interferon) production by corticotropin. J. Immunol. 132 (1984) 246-250
44. Karalis K.P., Kontopoulos E., Muglia L.J., and Majzoub J.A. Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine. Proc. Natl. Acad. Sci. USA 96 (1999) 7093-7097
45. Karalis K.P., Muglia L.J., Bae D., Hilderbrand H., and Majzoub J.A. CRH and the immune system. J. Neuroimmunol. 72 (1997) 131-136
46. Karalis K.P., Sano H., Redwine J., Listwak S., Wilder R.L., and Chrousos G.P. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254 (1991) 421-423
47. Kavelaars A., Ballieux R.E., and Heijnen C.J. The role of IL-1 in the corticotropin-releasing factor and arginine-vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood mononuclear cells. J. Immunol. 142 (1989) 2338-2342
48. Kavelaars A., Ballieux R.E., and Heijnen C.J. Differential effects of beta-endorphin on cAMP levels in human peripheral blood mononuclear cells. Brain Behav. Immun. 4 (1990) 171-179
49. Kavelaars A., Ballieux R.E., and Heijnen C.J. Beta-endorphin secretion by human peripheral blood mononuclear cells: regulation by glucocorticoids. Life Sci. 46 (1990) 1233-1240
50. Kavelaars A., Berkenbosch F., Croiset G., and Ballieux R.E. Induction of beta-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 126 (1990) 759-764
51. Kavelaars A., Ballieux R.E., and Heijnen C.J. Two different signalling pathways for the induction of immunoreactive beta-endorphin secretion by human peripheral blood mononuclear cells. Endocrinology 128 (1991) 765-770
52. Kay N., Allen J., and Morley J.E. Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sci. 35 (1984) 53-59
53. Kelley K.W., Brief S., Westly H.J., Novakofski J., Bechtel P.J., Simon J., and Walker E.B. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc. Natl. Acad. Sci USA 83 (1986) 5663-5667
54. Koff W.C., and Dunegan M.A. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J. Immunol. 135 (1985) 350-354
55. Koldzic-Zivanovic N., Tu H., Juelich T.L., Rady P.L., Tyring S.K., Hudnall S.D., Smith E.M., and Hughes T.K. Regulation of adrenal glucocorticoid synthesis by interleukin-10: a preponderance of IL-10 receptor in the adrenal zona fasciculata. Brain Behav. Immun. 20 (2006) 460-468
56. Kravchenco I., and Furalev V. Secretion of immunoreactive corticotropin releasing factor and adrenocorticotropic hormone by T- and B-lymphocytes in response to cellular stress factors. Biochem. Biophys. Res. Commun. 204 (1994) 828-834
57. Leu S.J., and Singh V. Modulation of natural killer cell-mediated lysis by corticotropin-releasing neurohormone. J. Neuroimmunol. 33 (1991) 253-260
58. Leu S.J., and Singh V. Stimulation of interleukin-6 production by corticotropin-releasing factor. Cell Immunol. 143 (1992) 220-227
59. Leu S.J., and Singh V. Suppression of in vitro antibody production by corticotropin-releasing factor neurohormone. J. Neuroimmunol. 45 (1993) 23-29
60. Lipton J.M., Zhao H., Ichiyama T., Barsh G.S., and Catania A. Mechanisms of antiinflammatory action of alpha-MSH peptides: in vivo and in vitro evidence. Ann. N. Y. Acad. Sci. 885 (1999) 173-182
61. Loh Y.P., Parish D., and Tuteja R. Purification and characterization of a paired basic residue-specific pro-opiomelanocortin converting enzyme from bovine pituitary intermediate lobe secretory vesicles. J. Biol. Chem. 260 (1985) 7194-7205
62. Lolait S.J., Clements J.A., Markwick A.J., Cheng C., McNally M., Smith A.I., and Funder J.W. Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J. Clin. Invest. 77 (1986) 1776-1779
63. Lyons P.D., and Blalock J.E. The kinetics of ACTH expression in rat leukocyte subpopulations. J. Neuroimmunol. 63 (1995) 103-112
64. Lyons P.D., and Blalock J.E. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J. Neuroimmunol. 78 (1997) 47-56
65. Mathews P.M., Froelich C.J., Sibbitt Jr. W.L., and Bankhurst A.D. Enhancement of natural cytotoxicity by beta-endorphin. J. Immunol. 130 (1983) 1658-1662
66. McGillis J.P., Park A., Rubin-Fletter P., Turck C., Dallman M.F., and Payan D.G. Stimulation of rat B-lymphocyte proliferation by corticotropin-releasing factor. J. Neurosci. Res. 23 (1989) 346-352
67. Mechanick J.I., Levin N., Roberts J.L., and Autelitano D.J. Proopiomelanocortin gene expression in a distinct population of rat spleen and lung leukocytes. Endocrinology 131 (1992) 518-525
68. Meyer III W.J., Smith E.M., Richards G.E., Cavallo A., Morrill A.C., and Blalock J.E. In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear lymphocytes from normal and ACTH-deficient individuals. J. Clin. Endocrinol. Metab. 64 (1987) 98-105
69. Mousa S.A., Machelska H., Schafer M., and Stein C. Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain. J. Neuroimmunol. 108 (2000) 160-170
70. Mousa S.A., Schafer M., Mitchell W.M., Hassan A.H., and Stein C. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur. J. Pharmacol. 311 (1996) 221-231
71. Muglia L., Jacobson L., Dikkes P., and Majzoub J.A. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373 (1995) 427-432
72. Muglia L.J., Bethin K., Jacobson L., Vogt S.K., and Majzoub J.A. Pituitary-adrenal axis regulation in CRH-deficient mice. Endocr. Res. 26 (2000) 1057-1066
73. Muglia L.J., Jacobson L., Weninger S.C., Karalis K.P., Jeong K., and Majzoub J.A. The physiology of corticotropin-releasing hormone deficiency in mice. Peptides 22 (2001) 725-731
74. Muglia L.J., Jenkins N.A., Gilbert D.J., Copeland N.G., and Majzoub J.A. Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J. Clin. Invest. 93 (1994) 2066-2072
75. Munck A., Guyre P.M., and Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5 (1984) 25-44
76. Munn N.A., and Lum L.G. Immunoregulatory effects of alpha-endorphin, beta-endorphin, methionine-enkephalin, and adrenocorticotropic hormone on anti-tetanus toxoid antibody synthesis by human lymphocytes. Clin. Immunol. Immunopathol. 52 (1989) 376-385
77. Oates E.L., Allaway G.P., Armstrong G.R., Boyajian R.A., Kehrl J.H., and Prabhakar B.S. Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. Effects of lymphotropic viruses. J. Biol. Chem. 263 (1988) 10041-10044
78. Pawlikowski M., Zelazowski P., Dohler K., and Stepien H. Effects of two neuropeptides, somatoliberin (GRF) and corticoliberin (CRF), on human lymphocyte natural killer activity. Brain Behav. Immun. 2 (1988) 50-56
79. Payne L.C., Weigent D.A., and Blalock J.E. Induction of pituitary sensitivity to interleukin-1: a new function for corticotropin-releasing hormone. Biochem. Biophys. Res. Commun. 198 (1994) 480-484
80. Przewlocki R., Hassan A.H., Lason W., Epplen C., Herz A.X., and Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 48 (1992) 491-500
81. Radulovic M., Dautzenberg F.M., Sydow S., Radulovic J., and Spiess J. Corticotropin-releasing factor receptor 1 in mouse spleen: expression after immune stimulation and identification of receptor-bearing cells. J. Immunol. 162 (1999) 3013-3021
82. Rajora N., Ceriani G., Catania A., Star R.A., Murphy M., and Lipton J.M. alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J. Leukoc. Biol. 59 (1996) 248-253
83. Redei E. Immuno-reactive and bioactive corticotropin-releasing factor in rat thymus. Neuroendocrinology 55 (1992) 115-118
84. Reder A.T. Regulation of production of adrenocotricotropin-like proteins in human mononuclear cells. Immunology 77 (1992) 436-442
85. Rittner H.L.M., Brack A.M.D., Machelska H.P., Mousa S.A.P., Bauer M.P., Schafer M.M.D., and Stein C.M.D. Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95 (2001) 500-508
86. Schafer M., Carter L., and Stein C. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc. Natl. Acad. Sci USA 91 (1994) 4219-4223
87. Schafer M., Mousa S.A., and Stein C. Corticotropin-releasing factor in antinociception and inflammation. Eur. J. Pharmacol. 323 (1997) 1-10
88. Schafer M., Mousa S.A., Zhang Q., Carter L., and Stein C. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc. Natl. Acad. Sci. USA 93 (1996) 6096-6100
89. Schafer M., Zhou L., and Stein C. Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue. Neuroscience 82 (1998) 603-611
90. Singh V. Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J. Neuroimmunol. 23 (1989) 257-262
91. Singh V., and Fudenberg H.H. Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease. Immunol. Lett. 18 (1988) 5-8
92. Singh V., and Leu S.J. Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neurosci. Lett. 120 (1990) 151-154
93. Singh V., and Leu S.J. Corticotropin-releasing factor-induced production of cyclic AMP by human peripheral blood immunocytes. Immunol. Lett. 35 (1993) 239-245
94. Sitte N., Busch M., Mousa S.A., Labuz D., Rittner H., Gore C., Krause H., Stein C., and Schafer M. Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo. J. Neuroimmunol. 183 (2007) 133-145
95. Smith E.M. Corticotropin and immunoregulation. In: Scharrer B., Smith E.M., and Stefano G.B. (Eds). Neuropeptides and Immunoregulation (1994), Springer-Verlag, Berlin 28-45
96. Smith, E.M., 2002. Opioid peptides in immune cells. In: Malchelska, H., Stein, C. (Eds.), Immune Mechanisms of Analgesis R.G. Landes Co., Berlin, pp. 51-68.
97. Smith E.M. Opioid peptides in immune cells. Adv. Exp. Med. Biol. 521 (2003) 51-68
98. Smith E.M., and Blalock J.E. Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proc. Natl. Acad. Sci. USA 78 (1981) 7530-7534
99. Smith E.M., and Blalock J.E. The hormonal nature of the interferon system. Tex. Rep. Biol. Med. 41 (1981) 350-358
100. Smith E.M., Galin F.S., LeBoeuf R.D., Coppenhaver D.H., Harbour D.V., and Blalock J.E. Nucleotide and amino acid sequence of lymphocyte-derived corticotropin: endotoxin induction of a truncated peptide. Proc. Natl. Acad. Sci. USA 87 (1990) 1057-1060
101. Smith E.M., Hogan D., and Hughes Jr. T.K. Nuclear factor-kappa B is a pivotal regulatory factor for neuro-immune interactions. Brain Behav. Immun. 15 (2001) 184
102. Smith E.M., Hughes T.K., Cadet P., and Stefano G.B. Corticotropin-releasing factor-induced immunosuppression in human and invertebrate immunocytes. Cell Mol. Neurobiol. 12 (1992) 473-481
103. Smith E.M., Hughes Jr. T.K., Hashemi F., and Stefano G.B. Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection. Proc. Natl. Acad. Sci USA 89 (1992) 782-786
104. Smith, E.M., Johnson, E.W., 1989. A molecular basis for bidirectional communication between the neuroendocrine and immune systems. In: Hadden, J.W., Spreafico, F., Yamamura, Y., Austen, K.F., Dukor, P., Masek, K. (Eds.), Advances in Immunopharmacology, vol. 4. Pergamon Press, Oxford, pp. 47-54.
105. Smith E.M., Meyer W.J., and Blalock J.E. Virus-induced corticosterone in hypophysectomized mice: a possible lymphoid adrenal axis. Science 218 (1982) 1311-1312
106. Smith E.M., Morrill A.C., Meyer III W.J., and Blalock J.E. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 321 (1986) 881-882
107. Smith E.M., Phan M., Kruger T.E., Coppenhaver D.H., and Blalock J.E. Human lymphocyte production of immunoreactive thyrotropin. Proc. Natl. Acad. Sci USA 80 (1983) 6010-6013
108. Smith E., Gregg M., Hashemi F., Schott L., and Hughes T. Corticotropin releasing factor (CRF) activation of NF-κB-directed transcription in leukocytes. Cell. Mol. Neurobiol. (2006) 1-16
109. Smith E.M., Dalmeida W., and Hughes T.K. Signaling pathway-related gene expression in neuroimmunoregulation. J. Neuroimmunol. 147 (2004) 138-140
110. Stefano G.B., and Smith E.M. Adrenocorticotropin--a central trigger in immune responsiveness: tonal inhibition of immune activation. Med. Hypotheses 46 (1995) 471-478
111. Stein C., Gramsch C., Hassan A.H., Przewlocki R., Parsons C.G., Peter K., and Herz A. Local opioid receptors mediating antinociception in inflammation: endogenous ligands. In: Quirion R., Jhamandas K., and Gianoulakis C. (Eds). The International Nsarcotics Research Conference (INRC) '89 Alan R (1990), Liss, Inc., New York 425-427
112. Stein C., Gramsch C., and Herz A. Intrinsic mechanisms of antinociception in inflammation: Local opioid receptors and beta-endorphin. J. Neurosci. 10 (1990) 1292-1298
113. Stein C., Hassan A.H., Lehrberger K., Giefing J., and Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 342 (1993) 321-324
114. Stephanou A., Jessop D.S., Knight R.A., and Lightman S.L. Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behav. Immun. 4 (1990) 67-73
115. Stephanou A., Sarlis N.J., Knight R.A., Chowdrey H.S., and Lightman S.L. Response of pituitary and spleen pro-opiomelanocortin mRNA, and spleen and thymus interleukin-1 beta mRNA to adjuvant arthritis in the rat. J. Neuroimmunol. 37 (1992) 59-63
116. Tsatsanis C., Androulidaki A., Alissafi T., Charalampopoulos I., Dermitzaki E., Roger T., Gravanis A., and Margioris A.N. Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU1 and AP-1. J. Immunol. 176 3 (2006) 1869-1877
117. Tsatsanis C., Androulidaki A., Dermitzaki E., Charalampopoulos I., Spiess J., Gravanis A., and Margioris A.N. Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2. FEBS Lett. 579 (2005) 4259-4264
118. van Woudenberg A.D., Metzelaar M.J., van der Kleij A.A., de Wied D., Burbach J.P., and Wiegant V.M. Analysis of proopiomelanocortin (POMC) messenger ribonucleic acid and POMC-derived peptides in human peripheral blood mononuclear cells: no evidence for a lymphocyte-derived POMC system. Endocrinology 133 (1993) 1922-1933
119. Webster E., and De Souza E.B. Corticotropin-releasing factor receptors in mouse spleen: Identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides. Endocrinology 122 (1988) 609-617
120. Webster E., Elenkov I.J., and Chrousos G.P. Corticotropin-releasing hormone acts on immune cells to elicit pro-inflammatory responses. Mol. Psychiatry 2 (1997) 345-346
121. Webster E., Tracey D., Jutila M.A., Wolfe Jr. S.A., and De Souza E.B. Corticotropin-releasing factor receptors in mouse spleen: Identification of receptor-bearing cells as resident macrophages. Endocrinology 127 (1990) 440-452
122. Weigent D.A., and Blalock J.E. Production of peptide hormones and neurotransmitters by the immune system. Chem. Immunol. 69 (1997) 1-30
123. Westly H.J., Kleiss A.J., Kelley K.W., Wong P.K., and Yuen P.H. Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J. Exp. Med. 163 (1986) 1589-1594
124. Wilbert-Lampen U., Straube F., Trapp A., Deutschmann A., Plasse A., and Steinbeck G. Effects of corticotropin-releasing hormone (CRH) on monocyte function, mediated by CRH-receptor subtype R1 and R2: a potential link between mood disorders and endothelial dysfunction?. J. Cardiovasc. Pharmacol. 47 1 (2006) 110-116
125. Zhao J., and Karalis K.P. Regulation of nuclear factor-κB by corticotropin-releasing hormone in mouse thymocytes. Mol. Endocrinol. 16 (2002) 2561-2570
126. Zhao J., and Karalis K.P. Regulation of NUCLEAR Factor-{kappa}B by corticotropin-releasing hormone in mouse thymocytes. Mol. Endocrinol. 16 (2002) 2561-2570